Global Duchenne Muscular Dystrophy Treatment Market Growth (Status and Outlook) 2026-2032

May 2026 | 82 pages | ID: GF50192C7144EN
LP Information

Abstracts

The global Duchenne Muscular Dystrophy Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Duchenne Muscular Dystrophy Treatment Industry Forecast” looks at past sales and reviews total world Duchenne Muscular Dystrophy Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Duchenne Muscular Dystrophy Treatment sales for 2026 through 2032. With Duchenne Muscular Dystrophy Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Duchenne Muscular Dystrophy Treatment industry.

This Insight Report provides a comprehensive analysis of the global Duchenne Muscular Dystrophy Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Duchenne Muscular Dystrophy Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Duchenne Muscular Dystrophy Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Duchenne Muscular Dystrophy Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Duchenne Muscular Dystrophy Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Duchenne Muscular Dystrophy Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• NSAIDs
• Corticosteroids
• Others

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• ITALFARMACO SpA
• FibroGen, Inc.
• Summit Therapeuticsplc
• PTC Therapeutics
• Santhera Pharmaceuticals
• Sarepta Therapeutics, Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Duchenne Muscular Dystrophy Treatment Market Size (2021-2032)
  2.1.2 Duchenne Muscular Dystrophy Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Duchenne Muscular Dystrophy Treatment by Country/Region (2021, 2025 & 2032)
2.2 Duchenne Muscular Dystrophy Treatment Segment by Type
  2.2.1 NSAIDs
  2.2.2 Corticosteroids
  2.2.3 Others
  2.2.4 Duchenne Muscular Dystrophy Treatment Market Size by Type
    2.2.4.1 Duchenne Muscular Dystrophy Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type (2021-2026)
2.3 Duchenne Muscular Dystrophy Treatment Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Others
  2.3.4 Duchenne Muscular Dystrophy Treatment Market Size by Application
    2.3.4.1 Duchenne Muscular Dystrophy Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Duchenne Muscular Dystrophy Treatment Market Size Market Share by Application (2021-2026)

3 DUCHENNE MUSCULAR DYSTROPHY TREATMENT MARKET SIZE BY PLAYER

3.1 Duchenne Muscular Dystrophy Treatment Market Size Market Share by Player
  3.1.1 Global Duchenne Muscular Dystrophy Treatment Revenue by Player (2021-2026)
  3.1.2 Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Duchenne Muscular Dystrophy Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 DUCHENNE MUSCULAR DYSTROPHY TREATMENT BY REGION

4.1 Duchenne Muscular Dystrophy Treatment Market Size by Region (2021-2026)
4.2 Global Duchenne Muscular Dystrophy Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Duchenne Muscular Dystrophy Treatment Market Size Growth (2021-2026)
4.4 APAC Duchenne Muscular Dystrophy Treatment Market Size Growth (2021-2026)
4.5 Europe Duchenne Muscular Dystrophy Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Duchenne Muscular Dystrophy Treatment Market Size by Country (2021-2026)
5.2 Americas Duchenne Muscular Dystrophy Treatment Market Size by Type (2021-2026)
5.3 Americas Duchenne Muscular Dystrophy Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Duchenne Muscular Dystrophy Treatment Market Size by Region (2021-2026)
6.2 APAC Duchenne Muscular Dystrophy Treatment Market Size by Type (2021-2026)
6.3 APAC Duchenne Muscular Dystrophy Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Duchenne Muscular Dystrophy Treatment Market Size by Country (2021-2026)
7.2 Europe Duchenne Muscular Dystrophy Treatment Market Size by Type (2021-2026)
7.3 Europe Duchenne Muscular Dystrophy Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Duchenne Muscular Dystrophy Treatment by Region (2021-2026)
8.2 Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL DUCHENNE MUSCULAR DYSTROPHY TREATMENT MARKET FORECAST

10.1 Global Duchenne Muscular Dystrophy Treatment Forecast by Region (2027-2032)
  10.1.1 Global Duchenne Muscular Dystrophy Treatment Forecast by Region (2027-2032)
  10.1.2 Americas Duchenne Muscular Dystrophy Treatment Forecast
  10.1.3 APAC Duchenne Muscular Dystrophy Treatment Forecast
  10.1.4 Europe Duchenne Muscular Dystrophy Treatment Forecast
  10.1.5 Middle East & Africa Duchenne Muscular Dystrophy Treatment Forecast
10.2 Americas Duchenne Muscular Dystrophy Treatment Forecast by Country (2027-2032)
  10.2.1 United States Market Duchenne Muscular Dystrophy Treatment Forecast
  10.2.2 Canada Market Duchenne Muscular Dystrophy Treatment Forecast
  10.2.3 Mexico Market Duchenne Muscular Dystrophy Treatment Forecast
  10.2.4 Brazil Market Duchenne Muscular Dystrophy Treatment Forecast
10.3 APAC Duchenne Muscular Dystrophy Treatment Forecast by Region (2027-2032)
  10.3.1 China Duchenne Muscular Dystrophy Treatment Market Forecast
  10.3.2 Japan Market Duchenne Muscular Dystrophy Treatment Forecast
  10.3.3 Korea Market Duchenne Muscular Dystrophy Treatment Forecast
  10.3.4 Southeast Asia Market Duchenne Muscular Dystrophy Treatment Forecast
  10.3.5 India Market Duchenne Muscular Dystrophy Treatment Forecast
  10.3.6 Australia Market Duchenne Muscular Dystrophy Treatment Forecast
10.4 Europe Duchenne Muscular Dystrophy Treatment Forecast by Country (2027-2032)
  10.4.1 Germany Market Duchenne Muscular Dystrophy Treatment Forecast
  10.4.2 France Market Duchenne Muscular Dystrophy Treatment Forecast
  10.4.3 UK Market Duchenne Muscular Dystrophy Treatment Forecast
  10.4.4 Italy Market Duchenne Muscular Dystrophy Treatment Forecast
  10.4.5 Russia Market Duchenne Muscular Dystrophy Treatment Forecast
10.5 Middle East & Africa Duchenne Muscular Dystrophy Treatment Forecast by Region (2027-2032)
  10.5.1 Egypt Market Duchenne Muscular Dystrophy Treatment Forecast
  10.5.2 South Africa Market Duchenne Muscular Dystrophy Treatment Forecast
  10.5.3 Israel Market Duchenne Muscular Dystrophy Treatment Forecast
  10.5.4 Turkey Market Duchenne Muscular Dystrophy Treatment Forecast
10.6 Global Duchenne Muscular Dystrophy Treatment Forecast by Type (2027-2032)
10.7 Global Duchenne Muscular Dystrophy Treatment Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Duchenne Muscular Dystrophy Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 ITALFARMACO SpA
  11.1.1 ITALFARMACO SpA Company Information
  11.1.2 ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Product Offered
  11.1.3 ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 ITALFARMACO SpA Main Business Overview
  11.1.5 ITALFARMACO SpA Latest Developments
11.2 FibroGen, Inc.
  11.2.1 FibroGen, Inc. Company Information
  11.2.2 FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Product Offered
  11.2.3 FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 FibroGen, Inc. Main Business Overview
  11.2.5 FibroGen, Inc. Latest Developments
11.3 Summit Therapeuticsplc
  11.3.1 Summit Therapeuticsplc Company Information
  11.3.2 Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Product Offered
  11.3.3 Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Summit Therapeuticsplc Main Business Overview
  11.3.5 Summit Therapeuticsplc Latest Developments
11.4 PTC Therapeutics
  11.4.1 PTC Therapeutics Company Information
  11.4.2 PTC Therapeutics Duchenne Muscular Dystrophy Treatment Product Offered
  11.4.3 PTC Therapeutics Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 PTC Therapeutics Main Business Overview
  11.4.5 PTC Therapeutics Latest Developments
11.5 Santhera Pharmaceuticals
  11.5.1 Santhera Pharmaceuticals Company Information
  11.5.2 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Product Offered
  11.5.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Santhera Pharmaceuticals Main Business Overview
  11.5.5 Santhera Pharmaceuticals Latest Developments
11.6 Sarepta Therapeutics, Inc.
  11.6.1 Sarepta Therapeutics, Inc. Company Information
  11.6.2 Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Product Offered
  11.6.3 Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Sarepta Therapeutics, Inc. Main Business Overview
  11.6.5 Sarepta Therapeutics, Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Duchenne Muscular Dystrophy Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Duchenne Muscular Dystrophy Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of NSAIDs
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Others
Table 6. Duchenne Muscular Dystrophy Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Duchenne Muscular Dystrophy Treatment Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type (2021-2026)
Table 9. Duchenne Muscular Dystrophy Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Duchenne Muscular Dystrophy Treatment Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Duchenne Muscular Dystrophy Treatment Market Size Market Share by Application (2021-2026)
Table 12. Global Duchenne Muscular Dystrophy Treatment Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Player (2021-2026)
Table 14. Duchenne Muscular Dystrophy Treatment Key Players Head office and Products Offered
Table 15. Duchenne Muscular Dystrophy Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Duchenne Muscular Dystrophy Treatment Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Duchenne Muscular Dystrophy Treatment Market Size Market Share by Region (2021-2026)
Table 20. Global Duchenne Muscular Dystrophy Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Duchenne Muscular Dystrophy Treatment Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Duchenne Muscular Dystrophy Treatment Market Size Market Share by Country (2021-2026)
Table 24. Americas Duchenne Muscular Dystrophy Treatment Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type (2021-2026)
Table 26. Americas Duchenne Muscular Dystrophy Treatment Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Duchenne Muscular Dystrophy Treatment Market Size Market Share by Application (2021-2026)
Table 28. APAC Duchenne Muscular Dystrophy Treatment Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Duchenne Muscular Dystrophy Treatment Market Size Market Share by Region (2021-2026)
Table 30. APAC Duchenne Muscular Dystrophy Treatment Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Duchenne Muscular Dystrophy Treatment Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Duchenne Muscular Dystrophy Treatment Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Duchenne Muscular Dystrophy Treatment Market Size Market Share by Country (2021-2026)
Table 34. Europe Duchenne Muscular Dystrophy Treatment Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Duchenne Muscular Dystrophy Treatment Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Duchenne Muscular Dystrophy Treatment
Table 40. Key Market Challenges & Risks of Duchenne Muscular Dystrophy Treatment
Table 41. Key Industry Trends of Duchenne Muscular Dystrophy Treatment
Table 42. Global Duchenne Muscular Dystrophy Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Duchenne Muscular Dystrophy Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Duchenne Muscular Dystrophy Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Duchenne Muscular Dystrophy Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. ITALFARMACO SpA Details, Company Type, Duchenne Muscular Dystrophy Treatment Area Served and Its Competitors
Table 47. ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Product Offered
Table 48. ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. ITALFARMACO SpA Main Business
Table 50. ITALFARMACO SpA Latest Developments
Table 51. FibroGen, Inc. Details, Company Type, Duchenne Muscular Dystrophy Treatment Area Served and Its Competitors
Table 52. FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Product Offered
Table 53. FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. FibroGen, Inc. Main Business
Table 55. FibroGen, Inc. Latest Developments
Table 56. Summit Therapeuticsplc Details, Company Type, Duchenne Muscular Dystrophy Treatment Area Served and Its Competitors
Table 57. Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Product Offered
Table 58. Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Summit Therapeuticsplc Main Business
Table 60. Summit Therapeuticsplc Latest Developments
Table 61. PTC Therapeutics Details, Company Type, Duchenne Muscular Dystrophy Treatment Area Served and Its Competitors
Table 62. PTC Therapeutics Duchenne Muscular Dystrophy Treatment Product Offered
Table 63. PTC Therapeutics Duchenne Muscular Dystrophy Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. PTC Therapeutics Main Business
Table 65. PTC Therapeutics Latest Developments
Table 66. Santhera Pharmaceuticals Details, Company Type, Duchenne Muscular Dystrophy Treatment Area Served and Its Competitors
Table 67. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Product Offered
Table 68. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Santhera Pharmaceuticals Main Business
Table 70. Santhera Pharmaceuticals Latest Developments
Table 71. Sarepta Therapeutics, Inc. Details, Company Type, Duchenne Muscular Dystrophy Treatment Area Served and Its Competitors
Table 72. Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Product Offered
Table 73. Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Sarepta Therapeutics, Inc. Main Business
Table 75. Sarepta Therapeutics, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Duchenne Muscular Dystrophy Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Duchenne Muscular Dystrophy Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Duchenne Muscular Dystrophy Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Duchenne Muscular Dystrophy Treatment Sales Market Share by Country/Region (2025)
Figure 8. Duchenne Muscular Dystrophy Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type in 2025
Figure 10. Duchenne Muscular Dystrophy Treatment in Hospital
Figure 11. Global Duchenne Muscular Dystrophy Treatment Market: Hospital (2021-2026) & ($ millions)
Figure 12. Duchenne Muscular Dystrophy Treatment in Clinic
Figure 13. Global Duchenne Muscular Dystrophy Treatment Market: Clinic (2021-2026) & ($ millions)
Figure 14. Duchenne Muscular Dystrophy Treatment in Others
Figure 15. Global Duchenne Muscular Dystrophy Treatment Market: Others (2021-2026) & ($ millions)
Figure 16. Global Duchenne Muscular Dystrophy Treatment Market Size Market Share by Application in 2025
Figure 17. Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Player in 2025
Figure 18. Global Duchenne Muscular Dystrophy Treatment Market Size Market Share by Region (2021-2026)
Figure 19. Americas Duchenne Muscular Dystrophy Treatment Market Size 2021-2026 ($ millions)
Figure 20. APAC Duchenne Muscular Dystrophy Treatment Market Size 2021-2026 ($ millions)
Figure 21. Europe Duchenne Muscular Dystrophy Treatment Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size 2021-2026 ($ millions)
Figure 23. Americas Duchenne Muscular Dystrophy Treatment Value Market Share by Country in 2025
Figure 24. United States Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Duchenne Muscular Dystrophy Treatment Market Size Market Share by Region in 2025
Figure 29. APAC Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type (2021-2026)
Figure 30. APAC Duchenne Muscular Dystrophy Treatment Market Size Market Share by Application (2021-2026)
Figure 31. China Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. India Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Duchenne Muscular Dystrophy Treatment Market Size Market Share by Country in 2025
Figure 38. Europe Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type (2021-2026)
Figure 39. Europe Duchenne Muscular Dystrophy Treatment Market Size Market Share by Application (2021-2026)
Figure 40. Germany Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 41. France Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Duchenne Muscular Dystrophy Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 54. APAC Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 55. Europe Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 57. United States Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 58. Canada Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 59. Mexico Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 60. Brazil Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 61. China Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 62. Japan Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 63. Korea Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 65. India Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 66. Australia Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 67. Germany Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 68. France Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 69. UK Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 70. Italy Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 71. Russia Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 72. Egypt Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 73. South Africa Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 74. Israel Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 75. Turkey Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)
Figure 76. Global Duchenne Muscular Dystrophy Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Duchenne Muscular Dystrophy Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Duchenne Muscular Dystrophy Treatment Market Size 2027-2032 ($ millions)